Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Aurinia Pharmaceuticals Ord Shs (NQ: AUPH)
14.01 USD  -0.16 (-1.13%)
Official Closing Price  /  Updated: 7:54 PM EDT, Aug 14, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 914,900
Open 14.19
Bid (Size) 14.00 (19)
Ask (Size) 14.04 (1)
Prev. Close 14.17
Today's Range 13.90 - 14.21
52wk Range 3.520 - 21.93
Shares Outstanding 84,478,054
Dividend Yield N/A
Performance
YTD
-34.72%
-34.72%
1 Month
-4.76%
-4.76%
3 Month
-18.36%
-18.36%
6 Month
-25.12%
-25.12%
1 Year
+148.40%
+148.40%
Top News
More News
Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational Highlights
AURINIA REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS Read More
from Business Wire News Releases
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat at the... Read More
from Business Wire News Releases
More News
Read More
Short Interest Ratio Indicates Bullish Canadian Stocks: $PAAS $REAL $AUP
category The Market Signal
from The Market Signal
Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020
from Business Wire News Releases
Aurinia Closes US$200 Million Public Offering of Common Shares
from Business Wire News Releases
Recap: Aurinia Pharmaceuticals Q2 Earnings
category AUPH , Market News , Earnings , and 1 more.
from Benzinga
Aurinia Prices US$200 Million Public Offering of Common Shares
from Business Wire News Releases
Aurinia Announces Public Offering of Common Shares
from Business Wire News Releases
Aurinia Announces U.S. Food and Drug Administration Acceptance of the Filing of New Drug Application and Priority Review for Voclosporin for the Treatment of Lupus Nephritis
from Business Wire News Releases
Mid-Afternoon Market Update: Dow Tumbles 400 Points; Milestone Pharmaceuticals Shares Gain
category HLX , Eurozone , Commodities , and 17 more.
from Benzinga
Mid-Day Market Update: Brightcove Surges On Upbeat Q2 Results; Aurinia Pharmaceuticals Shares Slide
category Eurozone , Commodities , NOVA , and 17 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.